ArticleCureus2025
Implementing Robotic Gynecologic Surgery: Early Outcomes From a Tertiary Care Hospital in Portugal.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Implementation of a robotic surgery program in Peru: a retrospective cohort study of case mix, perioperative outcomes, and predictors of operative time.Journal of robotic surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Robotic surgery is increasingly used in minimally invasive gynecologic procedures. In Portugal, its integration into the National Health Service is still recent. This study presents the early clinical experience of a Portuguese tertiary center with robot-assisted gynecologic surgery. Materials and methods This was a retrospective, observational, and descriptive study based on the analysis of clinical charts from patients who underwent robot-assisted gynecologic surgery between October 2022 and December 2024. Demographic, intraoperative, and postoperative variables were evaluated, as well as histopathological results. Results A total of 109 patients underwent robot-assisted gynecologic surgery during the study period. The median patient age was 55 years, and the median BMI was 26.6 kg/m². The main surgical indication was adnexal tumor in 46 patients (42.2%), followed by endometrial tumor or its precursors in 33 patients (30.3%). The most commonly performed procedure was total hysterectomy (69.7%). The median operative time was 193 minutes, and estimated blood loss was less than 100 mL in most cases (66.1%). The conversion rate to laparotomy was 0.9%, and the median length of hospital stay was one day. Complications occurred in 10.1% of patients, most of which were Clavien-Dindo grade I or II. The readmission rate was 2.8%. Conclusion The implementation of robotic-assisted gynecologic surgery in our center was associated with favorable short-term outcomes, including low complication and readmission rates, minimal blood loss, and rapid recovery. While limited to a single-center experience, this study adds to the growing evidence on the safe and feasible introduction of robotic surgery in gynecologic practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.